Mounjaro hits shelves in India: How Eli Lilly’s weight loss drug compares with Ozempic — price, side effects and more
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
Why is Mounjaro getting so much attention? Is it safer than Ozempic as a weight loss drug?
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
Studying structure of G protein-coupled receptor kinases could improve an array of drugs
Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...
Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects
Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...
Eli Lilly's weight loss drug Mounjaro launched in India; check prices, how it works
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Labiotech.eu11h
Depression drug trials are failing—and placebos are to blame
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
Weight Loss Drug Mounjaro Launched In India To Tackle Obesity: Is It More Effective Than Ozempic?
Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...
Devdiscourse1d
Eli Lilly Launches Innovative Drug 'Mounjaro' to Combat Obesity and Diabetes in India
Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...
How drugs like Wegovy might affect kids in the long term
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
India Today on MSN16h
Mounjaro enters India as weight-loss drug, but doctors warn against misuse
While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.
Australian Broadcasting Corporation15d
How Ozempic and other GLP-1 agonist drugs turn down 'food noise' and cravings
When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but in how she thought about food. Where the smell of hot chips in the deep ...